458 related articles for article (PubMed ID: 12037011)
21. Pathological changes in the vitreoretinal junction 1: epiretinal membrane formation.
Snead DR; James S; Snead MP
Eye (Lond); 2008 Oct; 22(10):1310-7. PubMed ID: 18344963
[TBL] [Abstract][Full Text] [Related]
22. Vitreous and serum levels of platelet-derived growth factor and their correlation in patients with proliferative diabetic retinopathy.
Praidou A; Klangas I; Papakonstantinou E; Androudi S; Georgiadis N; Karakiulakis G; Dimitrakos S
Curr Eye Res; 2009 Feb; 34(2):152-61. PubMed ID: 19219687
[TBL] [Abstract][Full Text] [Related]
23. Platelet-derived growth factor-B/v-sis confers a tumorigenic and metastatic phenotype to human T98G glioblastoma cells.
Potapova O; Fakhrai H; Baird S; Mercola D
Cancer Res; 1996 Jan; 56(2):280-6. PubMed ID: 8542581
[TBL] [Abstract][Full Text] [Related]
24. [Immunohistologic study of the epiretinal membranes in proliferative diabetic retinopathy and retinal detachment with vitreo-retinal proliferation].
Baudouin C; Gastaud P; Gordon B; Lapalus P; Bazan NG; Righini M; Peyman GA
Ophtalmologie; 1990; 4(1):53-5. PubMed ID: 2250942
[TBL] [Abstract][Full Text] [Related]
25. Expression of complement component 3 (C3) from an adenovirus leads to pathology in the murine retina.
Cashman SM; Desai A; Ramo K; Kumar-Singh R
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3436-45. PubMed ID: 21357400
[TBL] [Abstract][Full Text] [Related]
26. [Electron-immunostaining characteristics of platelet-derived growth factor, transforming growth factor beta1 and their receptors in epiretinal membranes].
Wang F; Xu X; Zhang X; Yan Y
Zhonghua Yan Ke Za Zhi; 2000 Sep; 36(5):369-71, 24. PubMed ID: 11853632
[TBL] [Abstract][Full Text] [Related]
27. Diverse NF-kappaB expression in epiretinal membranes after human diabetic retinopathy and proliferative vitreoretinopathy.
Harada C; Harada T; Mitamura Y; Quah HM; Ohtsuka K; Kotake S; Ohno S; Wada K; Takeuchi S; Tanaka K
Mol Vis; 2004 Jan; 10():31-6. PubMed ID: 14737065
[TBL] [Abstract][Full Text] [Related]
28. IL-10 and antibodies to TGF-beta2 and PDGF inhibit RPE-mediated retinal contraction.
Carrington L; McLeod D; Boulton M
Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1210-6. PubMed ID: 10752962
[TBL] [Abstract][Full Text] [Related]
29. Different expression of vascular endothelial growth factor and pigment epithelium-derived factor between diabetic and non-diabetic epiretinal membranes.
Nam DH; Oh J; Roh JH; Huh K
Ophthalmologica; 2009; 223(3):188-91. PubMed ID: 19182495
[TBL] [Abstract][Full Text] [Related]
30. Tractional force generation by porcine Müller cells: stimulation by growth factors in human vitreous.
Hardwick C; Feist R; Morris R; White M; Witherspoon D; Angus R; Guidry C
Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2053-63. PubMed ID: 9331269
[TBL] [Abstract][Full Text] [Related]
31. Platelet-derived growth factor plays a key role in proliferative vitreoretinopathy.
Andrews A; Balciunaite E; Leong FL; Tallquist M; Soriano P; Refojo M; Kazlauskas A
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2683-9. PubMed ID: 10509666
[TBL] [Abstract][Full Text] [Related]
32. Immunoreactive ET-1 in the vitreous humor and epiretinal membranes of patients with proliferative vitreoretinopathy.
Roldán-Pallarés M; Rollín R; Mediero A; Martínez-Montero JC; Fernández-Cruz A; Bravo-Llata C; Fernández-Durango R
Mol Vis; 2005 Jul; 11():461-71. PubMed ID: 16030497
[TBL] [Abstract][Full Text] [Related]
33. The effect of alkylphosphocholines on intraretinal proliferation initiated by experimental retinal detachment.
Eibl KH; Lewis GP; Betts K; Linberg KA; Gandorfer A; Kampik A; Fisher SK
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1305-11. PubMed ID: 17325177
[TBL] [Abstract][Full Text] [Related]
34. Y1 receptor of neuropeptide Y as a glial marker in proliferative vitreoretinopathy and diseased human retina.
Cantó Soler MV; Gallo JE; Dodds RA; Hökfelt T; Villar MJ; Suburo AM
Glia; 2002 Sep; 39(3):320-4. PubMed ID: 12203398
[TBL] [Abstract][Full Text] [Related]
35. Glial reactivity, an early feature of diabetic retinopathy.
Rungger-Brändle E; Dosso AA; Leuenberger PM
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1971-80. PubMed ID: 10845624
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical study of angiogenesis and proliferative activity in epiretinal membranes.
Tsanou E; Ioachim E; Stefaniotou M; Gorezis S; Charalabopoulos K; Bagli H; Peschos D; Psilas K; Agnantis NJ
Int J Clin Pract; 2005 Oct; 59(10):1157-61. PubMed ID: 16178982
[TBL] [Abstract][Full Text] [Related]
37. Oligodendrocyte precursor hypercellularity and abnormal retina development in mice overexpressing PDGF-B in myelinating tracts.
Forsberg-Nilsson K; Erlandsson A; Zhang XQ; Ueda H; Svensson K; Nistér M; Trapp BD; Peterson AC; Westermark B
Glia; 2003 Feb; 41(3):276-89. PubMed ID: 12528182
[TBL] [Abstract][Full Text] [Related]
38. The effect of insulin and glucose levels on retinal glial cell activation and pigment epithelium-derived fibroblast growth factor-2.
Layton CJ; Becker S; Osborne NN
Mol Vis; 2006 Jan; 12():43-54. PubMed ID: 16446701
[TBL] [Abstract][Full Text] [Related]
39. Assessment of the integrin alpha5beta1 antagonist JSM6427 in proliferative vitreoretinopathy using in vitro assays and a rabbit model of retinal detachment.
Zahn G; Volk K; Lewis GP; Vossmeyer D; Stragies R; Heier JS; Daniel PE; Adamis AP; Chapin EA; Fisher SK; Holz FG; Löffler KU; Knolle J
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1028-35. PubMed ID: 19815730
[TBL] [Abstract][Full Text] [Related]
40. GLUT1 glucose transporter expression in the diabetic and nondiabetic human eye.
Kumagai AK; Glasgow BJ; Pardridge WM
Invest Ophthalmol Vis Sci; 1994 May; 35(6):2887-94. PubMed ID: 8188484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
